RE:Not expecting much tomorrow...Not expecting great things either - IMHO best that we can expect for NMIBC is a clear presentation of the results and how they relate to optimally, part optimally and non-optimally treated patients.
The fact that Rutherrin - their by far superior PS/RS in terms of safety efficacy and applicability - is only now (we hope!) going through toxicity some 6 years`after its`virtues were extolled to us represents one of the many imponderables here and who knows maybe not entirely unrelated to factors discussed earlier?